Found 50 matching trials
Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations PHASE1 Dolutegravir (DTG) and lamivudine (3TC) are indicated in combination with o...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants PHASE3 The primary objective of this study is to evaluate the efficacy of switchin...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2) PHASE3 This study will compare safety, efficacy, and tolerability of a two drug re...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Comprehensive HIV Prevention Package for MSM in Port Elizabeth NA The purpose of this study is to evaluate the acceptability and uptake of a ...
Show More Location
Human Sciences Research Council
Learn More & Join Trial
Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity PHASE4 This is a phase IV, open label, multicentre trial that will be taking place...
Show More Location
Chelsea and Westminster Hospital
Learn More & Join Trial
Study to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult Subjects PHASE1 This study is designed to estimate the two-way drug interaction between DCV...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Long-Acting Treatment in Adolescents (LATA) PHASE3 The LATA trial will find out if taking a long-acting injectable form of HIV...
Show More Learn More & Join Trial
A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults PHASE2 This is a phase 2b, randomized, multicenter, parallel group, partially blin...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF PHASE3 This study will evaluate the efficacy of switching from emtricitabine/tenof...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART N/A The goal of the project is to determine the difference in immune activation...
Show More Status
Enrolling By Invitation
Location
University of Washington Positive Research and the Gastroenterology Clinic at Harborview Medical Center
Learn More & Join Trial